BruceFlorman wrote:Okay. To be honest, I pretty much stopped reading at the end of the abstract.
That's why they write them!
BruceFlorman wrote:But the athlete in question is a woman. And if "drug-induced performance enhancement by hCG or estrogen blockers is highly unlikely", then why would this be something that WADA is reporting to the VFLA as a doping violation?
Quite simply, it's because it's on the WADA banned list in Section 4 (S4). You didn't actually believe that a lack of actual performance enhancement would stop WADA in its tracks?
S4. AGENTS WITH ANTI-ESTROGENIC ACTIVITY
The following classes of anti-estrogenic substances are prohibited:
1. Aromatase inhibitors including, but not limited to, anastrozole,
letrozole, aminoglutethimide, exemestane, formestane, testolactone.
2. Selective Estrogen Receptor Modulators (SERMs) including, but not
limited to, raloxifene, tamoxifen, toremifene.
3. Other anti-estrogenic substances including, but not limited to,
clomiphene, cyclofenil, fulvestrant.